ELECTRONIC QUALITY MANAGEMENT SYSTEM(EQMS): BENEFITS, IMPLEMENTATION, REGULATORY AND CHALLENGES
Abstract
In order to guarantee product safety, efficacy, and regulatory compliance, the pharmaceutical sector needs strong quality control systems. Electronic Quality Management Systems (eQMS) are gradually replacing traditional paper-based Quality Management Systems (QMS) as a result of expanding regulatory requirements and digital technology improvements. An eQMS enhances documentation, traceability, efficiency, and compliance management by integrating quality-related procedures into a single electronic platform. Major advantages of eQMS include enhanced data integrity, improved regulatory compliance, reduction in human error, However, implementation of eQMS is associated with several challenges. Regulations pertaining to electronic systems and data integrity have been established by regulatory bodies such as the USFDA, European Medicines Agency (EMA), ICH, and WHO. Compliance with FDA 21 CFR Part 11 principles is essential for successful implementation of eQMS. The article also highlights future trends such as cloud-based systems, artificial intelligence, predictive analytics, and Industry 4.0 integration that are transforming pharmaceutical quality management. Overall, eQMS represents a significant advancement in pharmaceutical quality assurance and operational excellence.
